Zicam Extreme Congestion Relief Spray
NDC Package 10237-464-15
Package Information
Zicam Extreme Congestion Relief (oxymetazoline hydrochloride) sprays is adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. This formulation utilizes a spray delivery system. Marketed by Church & Dwight Co., Inc., this product is identified by NDC 10237-464 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1000990 - oxymetazoline HCl 0.05 % Nasal Spray
- RxCUI: 1000990 - oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray
- RxCUI: 1000990 - oxymetazoline hydrochloride 0.05 % Nasal Spray
- RxCUI: 1001084 - Zicam Congestion Relief 0.05 % Nasal Spray
- RxCUI: 1001084 - oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Zicam Sinus Relief]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10237 - Church & Dwight Co., Inc.
- 10237-464 - Zicam Extreme Congestion Relief
- 10237-464-15 - 1 BOTTLE, PLASTIC in 1 CARTON / 15 mL in 1 BOTTLE, PLASTIC
- 10237-464 - Zicam Extreme Congestion Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10237-464-15 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 15 ml in 1 bottle, plastic of Zicam Extreme Congestion Relief, a human over the counter drug labeled by Church & Dwight Co., Inc.. This spray is formulated for nasal use and contains oxymetazoline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Church & Dwight Co., Inc. on October 01, 2021. The current certification is valid through December 31, 2026.
How is this Church & Dwight Co., Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10237046415. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.